Inventor · disambiguated record
Maurice Zauderer
Also filed as: ZAUDERER MAURICE
40 granted patents·23 pending applications·513 citations·filing 1997–2024
98Inventor score
Top patents by PatentIndex Score
63 records- 0197US9828435B2Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequencyVACCINEX INC·Filed 2014·Granted Nov 28, 2017·22 cites·19 claims
- 0297US7750125B2Antibodies that bind to the C35 polypeptideUNIV ROCHESTER·Filed 2007·Granted Jul 6, 2010·34 cites·29 claims
- 0396US9243068B2Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastasesVACCINEX INC·Filed 2014·Granted Jan 26, 2016·25 cites·11 claims
- 0496US7919594B2Human anti-CD100 antibodiesVACCINEX INC·Filed 2008·Granted Apr 5, 2011·55 cites·36 claims
- 0595US9249227B2Use of semaphorin-4D binding molecules for treating neurodegenerative disordersVACCINEX INC·Filed 2015·Granted Feb 2, 2016·18 cites·23 claims
- 0695US7563882B2Polynucleotides encoding antibodies that bind to the C35 polypeptideUNIV ROCHESTER·Filed 2003·Granted Jul 21, 2009·43 cites·26 claims
- 0795US6800442B2Methods of selecting polynucleotides encoding antigensUNIV ROCHESTER·Filed 2002·Granted Oct 5, 2004·41 cites·54 claims
- 0895US6706477B2Methods for producing polynucleotide libraries in vaccinia virusUNIV ROCHESTER·Filed 2001·Granted Mar 16, 2004·45 cites·62 claims
- 0994US9512224B2Use of semaphorin-4D binding molecules for treatment of atherosclerosisVACCINEX INC·Filed 2014·Granted Dec 6, 2016·11 cites·22 claims
- 1094US9090709B2Anti-SEMA4D antibodies and epitopesVACCINEX INC·Filed 2013·Granted Jul 28, 2015·18 cites·7 claims
- 1192US12006365B2Human anti-semaphorin 4D antibodyVACCINEX INC·Filed 2022·Granted Jun 11, 2024·1 cites·27 claims
- 1292US9890213B2Methods for the treatment of B cell-mediated inflammatory diseasesVACCINEX INC·Filed 2013·Granted Feb 13, 2018·10 cites·15 claims
- 1392US9598495B2Use of semaphorin-4D binding molecules for treating neurodegenerative disordersVACCINEX INC·Filed 2014·Granted Mar 21, 2017·16 cites·11 claims
- 1492US9371352B2Modified glycolipids and methods of making and using the sameVACCINEX INC·Filed 2013·Granted Jun 21, 2016·10 cites·29 claims
- 1592US8637026B2Anti-C35 antibody combination therapies and methodsZAUDERER MAURICE·Filed 2008·Granted Jan 28, 2014·14 cites·14 claims
- 1691US7858559B2In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cellsUNIV ROCHESTER·Filed 2001·Granted Dec 28, 2010·25 cites·42 claims
- 1790US10111950B2Modified glycolipids and methods of making and using the sameVACCINEX INC·Filed 2016·Granted Oct 30, 2018·5 cites·9 claims
- 1890US2025032609A1Use of semaphorin-4d antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasisVACCINEX INC·Filed 2024·Application pending·0 cites
- 1989US11078295B2Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastasesVACCINEX INC·Filed 2019·Granted Aug 3, 2021·2 cites·20 claims
- 2089US9708601B2Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virusVACCINEX INC·Filed 2013·Granted Jul 18, 2017·7 cites·4 claims
- 2188US9790271B2Methods for increasing immunoglobulin A levelsVACCINEX INC·Filed 2014·Granted Oct 17, 2017·10 cites·30 claims
- 2288US9701958B2Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunitsVACCINEX INC·Filed 2015·Granted Jul 11, 2017·4 cites·13 claims
- 2388US7067251B2Methods of directly selecting cells expressing inserts of interestUNIV ROCHESTER·Filed 2001·Granted Jun 27, 2006·14 cites·51 claims
- 2485US11597765B2Use of semaphorin-4D binding molecules for the treatment of Rett syndromeVACCINEX INC·Filed 2021·Granted Mar 7, 2023·2 cites·16 claims
- 2585US11427634B2Human anti-semaphorin 4D antibodyVACCINEX INC·Filed 2018·Granted Aug 30, 2022·4 cites·50 claims
- 2685US7268207B2Gene differentially expressed in breast and bladder cancer, and encoded polypeptidesUNIV ROCHESTER·Filed 2001·Granted Sep 11, 2007·14 cites·30 claims
- 2784US10385136B2Use of semaphorin-4D binding molecules for treating neurodegenerative disordersVACCINEX INC·Filed 2017·Granted Aug 20, 2019·3 cites·15 claims
- 2884US6872518B2Methods for selecting polynucleotides encoding T cell epitopesUNIV ROCHESTER·Filed 1997·Granted Mar 29, 2005·46 cites·36 claims
- 2982US10800853B2Use of semaphorin-4D binding molecules for treating neurodegenerative disordersVACCINEX INC·Filed 2019·Granted Oct 13, 2020·1 cites·15 claims
- 3080US11534488B2Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeabilityVACCINEX INC·Filed 2019·Granted Dec 27, 2022·1 cites·9 claims
- 3180US8741810B2In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cellsZAUDERER MAURICE·Filed 2007·Granted Jun 3, 2014·3 cites·15 claims
- 3280US2024309091A1Human anti-semaphorin 4d antibodyVACCINEX INC·Filed 2024·Application pending·0 cites
- 3379US12070500B2Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasisVACCINEX INC·Filed 2021·Granted Aug 27, 2024·0 cites·13 claims
- 3477US9809654B2Targeted CD1d moleculesROBERT BRUNO·Filed 2003·Granted Nov 7, 2017·9 cites·29 claims
- 3571US10526414B2Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasesVACCINEX INC·Filed 2017·Granted Jan 7, 2020·0 cites·6 claims
- 3670US7968688B2Antibodies that bind to the C35 polypeptideUNIV ROCHESTER·Filed 2009·Granted Jun 28, 2011·0 cites·21 claims
- 3770US7879990B2Polynucleotides encoding antibodies that bind to the C35 polypeptideUNIV ROCHESTER·Filed 2009·Granted Feb 1, 2011·0 cites·26 claims
- 3866US2025052757A1Use of PD-L1 Low Expression Status to Select Subjects for Cancer ImmunotherapyVACCINEX INC·Filed 2024·Application pending·0 cites
- 3965US7910551B2Gene differentially expressed in breast and bladder cancer and encoded polypeptidesUNIV ROCHESTER·Filed 2009·Granted Mar 22, 2011·0 cites·20 claims
- 4065US2004265900A1T cells specific for target antigens and methods and vaccines based thereonFiled 2004·Application pending·0 cites
- 4161US2023101618A1Predictive outcome profiling for use of an anti-semaphorin-4d binding molecule to treat neurodegenerative disordersVACCINEX INC·Filed 2022·Application pending·0 cites
- 4260US2023331863A1Combination therapy with semaphorin-4d blockade and htt-lowering agent for treatment of huntington's diseaseVACCINEX INC·Filed 2023·Application pending·0 cites
- 4359US10662422B2Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunitVACCINEX INC·Filed 2017·Granted May 26, 2020·0 cites·4 claims
- 4459US2005158323A1Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cellsVACCINEX INC·Filed 2004·Application pending·0 cites
- 4556US2007081942A1Gene differentially expressed in breast and bladder cancer, and encoded polypeptidesUNIV ROCHESTER·Filed 2006·Application pending·0 cites
- 4656US2005042218A1MHC class I - peptide-antibody conjugates with modified beta2-microglobulinVACCINEX INC·Filed 2004·Application pending·0 cites
- 4755US2004210037A1Targeted MHC class I alpha3 vaccine delivery systemsVACCINEX INC·Filed 2004·Application pending·0 cites
- 4854US2008305111A1Anti-C35 antibodies for treating cancerVACCINEX INC·Filed 2007·Application pending·0 cites
- 4954US2006160129A1Methods of producing a library and methods of selecting polynucleotides of interestUNIV ROCHESTER·Filed 2006·Application pending·0 cites
- 5053US2005266425A1Methods for producing and identifying multispecific antibodiesVACCINEX INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →